InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2024-09-11 00:00:00 ET · period of report 2024-09-10 · accession 0001127602-24-023825 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-09-11 2024-09-10 GILD Telman Deborah H EVP, GC, Corp. Affairs F - Tax $81.44 -307 20.7K -1% -$25.0K
D 2024-09-11 2024-09-10 GILD Telman Deborah H EVP, GC, Corp. Affairs M - OptEx — +639 21.0K +3% —
D 2024-09-11 2024-09-10 GILD Telman Deborah H EVP, GC, Corp. Affairs M - OptEx — -639 29.5K -2% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-09-10 F D 307 $81.44 20,707 D — —
2 Common Common Stock 2024-09-10 M A 639 — 21,014 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
3 Derivative Restricted Stock Unit 2024-09-10 M D 639 — 29,547 D — · — to — 639 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.